Activation of peripheral opioid receptors has no effect on heart rate variability      
Yazarlar (6)
Ender Ellidokuz
Manisa Celâl Bayar Üniversitesi, Türkiye
Dayimi Kaya
Sb Tepecik Research And Training Hospital, Izmir, Türkiye
Ihsan Uslan
Afyon Kocatepe Üniversitesi, Türkiye
Ali Metin Esen
Kosuyolu Heart Education And Research Hospital, Türkiye
Irfan Barutça
Kosuyolu Heart Education And Research Hospital, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Clinical Autonomic Research
Dergi ISSN 0959-9851 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 01-2008
Cilt No 18
Sayı 3
Sayfalar 145 / 149
DOI Numarası 10.1007/s10286-008-0469-9
Özet
Opioid receptors involved in regulating the motility of the gastrointestinal tract have been localized in both contractile and neuronal tissues. Trimebutine, a peripheral opioid receptor agonist, modulates gastrointestinal motor activity in both directions and also may act on cardiac tissue. This study investigated the effects of trimebutine in clinical doses on cardiac autonomic functions with heart rate variability. The effect of trimebutine on cardiac autonomic outflows was evaluated in 11 healthy subjects. Trimebutine (200 mg) or placebo was administered orally at random in a double-blind, cross-over manner. Continuous electrocardiography recordings were obtained before and after drug administration during three states: rest, controlled breathing, and a hand grip exercise. Heart rate variability analysis showed that there was no significant difference between subjects administered with placebo or trimebutine throughout rest, controlled breathing, or the hand grip exercise. We concluded that trimebutine, in clinical doses, has no significant effect on cardiac autonomic functions. © 2008 Springer.
Anahtar Kelimeler
Autonomic nervous system | Heart | HRV | Opioid receptor | Trimebutine